MAI Wealth Advisors »

Cue Biopharma shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $252 350 0.72
2025-06-30 $239 350 0.68
2025-03-31 $318 350 0.91
2024-12-31 $381 350 1.09

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Advisory Research
Renaissance Technologies
UBS Group
Stifel Financial
State Street Corporation
Susquehanna International
Angeles Wealth Management
Northern Trust

View all funds holding Cue Biopharma